Blue Bell, PA, United States of America

George C Buzby, Jr


Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 32(Granted Patents)


Location History:

  • Penllyn, PA (US) (1985)
  • Blue Bell, PA (US) (1985 - 1992)

Company Filing History:


Years Active: 1985-1992

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovations of George C Buzby, Jr.

Introduction

George C Buzby, Jr. is a notable inventor based in Blue Bell, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-arrhythmic agents. With a total of 14 patents to his name, Buzby has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents, Buzby has developed Class III anti-arrhythmic agents that provide new options for treating heart conditions. One of his inventions includes a formula where R.sup.1 is alkylsulfonamido, R.sup.2 is ethyl, R.sup.3 is hydrogen, R.sup.4 is ethyl, and n is 2 to 4, or a pharmaceutically acceptable salt thereof. Another significant patent is the N-aminoalkyl(perfluoroalkanoylaminophenyl)sulfonic acid amides, which features a formula where R.sup.1 is perfluoroalkanoylamino of 2 to 4 carbon atoms, positioned in the 3- or 4- position of the benzene ring.

Career Highlights

Buzby has spent a considerable part of his career at American Home Products Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a lasting impact on the medical community.

Collaborations

Throughout his career, Buzby has collaborated with esteemed colleagues such as Thomas J Colatsky and Michael W Winkley. These partnerships have fostered innovation and have led to the successful development of various pharmaceutical products.

Conclusion

George C Buzby, Jr. is a distinguished inventor whose work in anti-arrhythmic agents has made a significant impact in the field of medicine. His contributions continue to influence the development of effective treatments for heart conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…